311 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
7 May 24
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
8:05am
of product sales
Gross profit
Operating expenses:
Research and development
General and administrative
Sales and marketing
Total operating expenses
Loss
8-K
EX-99.1
h7nnom6lbb1d09ci6gg
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
8-K
EX-99.1
r75qfo2i
14 Nov 23
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:10pm
424B3
l5sv4 7m44zk1ln2iae
5 Sep 23
Prospectus supplement
9:14pm
8-K
EX-99.1
lki07j w3aa
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
8-K
EX-10.1
b26 xad8ylor3ncy
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.2
b5a ybg162i
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
ilexy5m
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
8-K
EX-99.1
xww25mv65
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm